4//SEC Filing
Nelson Stanton 4
Accession 0001209191-12-028628
CIK 0001272597other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:27 PM ET
Size
9.6 KB
Accession
0001209191-12-028628
Insider Transaction Report
Form 4
Nelson Stanton
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2012-05-14+330,000→ 330,000 totalExercise: $0.50From: 2012-05-14Exp: 2022-03-30→ Common Stock (330,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Board of Directors of Graymark Healthcare, Inc. on March 30, 2012, subject to shareholder approval of the stock option plan under which the option was granted. Graymark Healthcare Inc.'s shareholders approved the plan on May 14, 2012.
- [F2]The option vests in 6 equal installments as follows: (i) 12 months from the date of grant or upon Graymark Healthcare, Inc. achieving a positive EBITDA quarter, whichever occurs first, (ii) 24 months from the date of grant or upon Graymark Healthcare, Inc. achieving two consecutive positive EBITDA quarters, whichever occurs first, (iii) 36 months from the date of grant or upon achieving a certain EBITDA target for a trailing twelve month period, whichever occurs first, (iv) 48 months from the date of grant or upon achieving a certain EBITDA target for a trailing twelve month period, whichever occurs first, and (v) for the remaining two installments, upon achieving a certain EBITDA target for a trailing twelve month period.
Issuer
Graymark Healthcare, Inc.
CIK 0001272597
Entity typeother
Related Parties
1- filerCIK 0001297708
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:27 PM ET
- Size
- 9.6 KB